The adverse impact of TB, malaria and NTDs on development outcomes has resulted in new approaches and partnerships to tackle the global deficiencies in research and development, and treatment access. One such initiative is the strategic partnership between the Government of Japan and UNDP, which promotes research and development, and expedites access to and delivery of health technologies for the prevention, diagnosis and treatment of TB, malaria and NTDs. This partnership comprises two complementary components, which reflect the Government of Japan’s and UNDP’s strategic goals on global health